Aralez Pharmaceuticals   Report issue

For profit Phase 1 Phase 2 Phase 3
Founded: Chapel Hill NC United States (2015)
Status: Defunct (2018)

Organization Overview

First Clinical Trial
None
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2014

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Alternative names

ARALEZ PHARMS

Active Ingredients

Marketed Drugs (2)

metoprolol (lopressor) (1992)

vorapaxar (zontivity) (2014)

Drugs in Phase 3 Trials (9)

Key: Aralez Pharmaceuticals (0) Acquired (9)

acetylsalicylic acid (aspirin) (9 trials)

acitretin (soriatane) (1 trial)

celecoxib (celebrex) (4 trials)

diclofenac (voltaren) (1 trial)

esomeprazole (nexium) (13 trials)

misoprostol (cytotec) (1 trial)

naproxen (naprosyn) (19 trials)

omeprazole (prilosec) (6 trials)

sumatriptan (zecuity) (3 trials)

Drugs in Phase 2 Trials (2)

Key: Aralez Pharmaceuticals (0) Acquired (2)

ketorolac (acuvail) (1 trial)

lornoxicam (2 trials)

Drugs in Phase 1 Trials (1)

Key: Aralez Pharmaceuticals (0) Acquired (1)

clopidogrel (plavix) (1 trial)

Indications

Overview

  • Highest Phase: None
  • # of Trials: 31
  • # of Trial APIs: 12